NH300094 is a novel anti-schizophrenia candidate with unique characteristics of D2 receptor, D3 receptor antagonism, 5-HT1A,5-HT2A receptor antagonism and 5-HT1B inverse agonism. Here, HTR1B is linked to schizophrenia.